Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
PCRX on Nasdaq
Shares outstanding
42,998,448
Price per share
$25.88
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
47,958,837
Total reported value
$1,235,841,795
% of total 13F portfolios
0%
Share change
-2,766,388
Value change
-$66,493,899
Number of holders
235
Price from insider filings
$25.88
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $184,339,716 7,017,119 BlackRock, Inc. 31 Mar 2025
Doma Perpetual Capital Management LLC 6.8% 0% $67,693,102 2,936,794 0% Doma Perpetual Capital Management LLC 30 Dec 2025
RENAISSANCE TECHNOLOGIES LLC 5% -7.2% $55,101,440 -$6,633,198 2,138,201 -11% Renaissance Technologies LLC 01 Jul 2025
Pacer Advisors, Inc. 1.3% -81% $15,805,818 -$69,908,910 601,668 -82% Pacer Advisors, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 0.7% -88% $9,079,569 -$52,349,385 345,625 -85% Millennium Management LLC 31 Mar 2025

As of 30 Sep 2025, 235 institutional investors reported holding 47,958,837 shares of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX). This represents 112% of the company’s total 42,998,448 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) together control 87% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 17% 7,336,198 -5.9% 0% $189,053,823
VANGUARD GROUP INC 12% 5,197,567 -3.9% 0% $133,941,302
Doma Perpetual Capital Management LLC 6.3% 2,701,324 +50% 23% $69,613,119
DIMENSIONAL FUND ADVISORS LP 5% 2,163,473 +0.55% 0.01% $55,751,012
RENAISSANCE TECHNOLOGIES LLC 5% 2,138,201 -11% 0.07% $55,101,440
D. E. Shaw & Co., Inc. 4.5% 1,942,143 -14% 0.04% $50,049,025
STATE STREET CORP 4.4% 1,900,556 -2.6% 0% $48,977,328
Balyasny Asset Management L.P. 4.4% 1,885,071 -12% 0.1% $48,578,280
AMERICAN CENTURY COMPANIES INC 3.2% 1,378,513 +17% 0.02% $35,524,280
GOLDMAN SACHS GROUP INC 3% 1,309,988 +0.08% 0% $33,758,391
GEODE CAPITAL MANAGEMENT, LLC 2.8% 1,215,875 +6.4% 0% $31,337,405
MORGAN STANLEY 2.7% 1,142,761 +20% 0% $29,448,951
UBS Group AG 2% 854,861 -17% 0% $22,029,768
J. Goldman & Co LP 1.6% 669,140 +1.9% 0.65% $17,243,738
JACOBS LEVY EQUITY MANAGEMENT, INC 1.5% 652,580 -34% 0.07% $16,816,987
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 627,273 +10% 0% $16,164,825
Impax Asset Management Group plc 1.4% 600,027 +28% 0.09% $15,462,696
NORTHERN TRUST CORP 1.3% 574,299 -2% 0% $14,799,686
WELLINGTON MANAGEMENT GROUP LLP 1.2% 528,515 -3.1% 0% $13,619,831
Invesco Ltd. 1.2% 517,424 +7.9% 0% $13,334,017
GAGNON SECURITIES LLC 1% 449,717 +22% 2.3% $11,589,207
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1% 444,738 -3.4% 0.24% $11,460,898
JPMORGAN CHASE & CO 1% 436,198 +28% 0% $11,240,823
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.95% 409,997 0.02% $10,565,623
DEUTSCHE BANK AG\ 0.9% 385,917 +3.2% 0% $9,945,081

Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 949,897 $24,562,701 +$8,789,217 $25.88 25
2025 Q3 47,958,837 $1,235,841,795 -$66,493,899 $25.77 235
2025 Q2 50,544,840 $1,208,003,010 -$370,491 $23.90 231
2025 Q1 50,556,971 $1,256,353,159 +$32,555,416 $24.85 233
2024 Q4 49,919,475 $940,553,299 -$11,898,336 $18.84 228
2024 Q3 50,991,301 $767,581,533 -$172,726,407 $15.05 237
2024 Q2 51,910,467 $1,485,092,007 +$81,593,094 $28.61 276
2024 Q1 48,908,319 $1,429,034,946 +$11,654,259 $29.22 266
2023 Q4 82,976 $2,798,042 -$401,641 $33.74 3
2023 Q3 47,044,921 $1,443,241,170 -$4,932,711 $30.68 250
2023 Q2 46,596,317 $1,866,611,229 +$9,972,989 $40.07 248
2023 Q1 46,271,032 $1,887,750,783 -$74,971,543 $40.81 262
2022 Q4 48,289,798 $1,864,900,092 -$48,609,469 $38.61 264
2022 Q3 46,710,940 $2,484,615,288 +$82,301,484 $53.19 250
2022 Q2 48,835,641 $2,846,109,989 -$35,744,543 $58.30 267
2022 Q1 49,472,236 $3,773,422,860 -$68,034,652 $76.32 284
2021 Q4 50,538,132 $3,041,084,947 +$80,643,290 $60.17 261
2021 Q3 49,122,021 $2,750,750,684 -$7,819,684 $56.00 250
2021 Q2 49,193,880 $2,984,551,144 -$36,502,350 $60.68 253
2021 Q1 49,824,611 $3,491,786,523 -$29,008,205 $70.09 266
2020 Q4 50,345,010 $3,012,976,313 +$130,636,882 $59.84 255
2020 Q3 48,234,311 $2,899,041,363 -$13,389,825 $60.12 253
2020 Q2 48,700,111 $2,555,342,604 +$107,081,990 $52.47 240
2020 Q1 46,969,300 $1,573,895,724 +$37,650,121 $33.53 212
2019 Q4 45,333,155 $2,053,521,958 +$15,551,626 $45.30 224
2019 Q3 45,112,763 $1,719,043,471 +$75,604,597 $38.07 204
2019 Q2 42,770,732 $1,860,009,869 +$130,835,165 $43.49 215
2019 Q1 41,297,239 $1,571,743,648 +$30,043,571 $38.06 202
2018 Q4 39,834,464 $1,713,680,230 -$35,168,117 $43.02 198
2018 Q3 40,386,553 $1,984,886,486 -$82,855,850 $49.15 178
2018 Q2 42,445,174 $1,357,931,151 -$4,226,675 $32.05 145
2018 Q1 43,568,892 $1,357,193,862 +$18,538,136 $31.15 161
2017 Q4 41,553,917 $1,896,728,195 -$63,912,857 $45.65 179
2017 Q3 43,507,273 $1,635,186,296 +$59,779,455 $37.55 175
2017 Q2 41,016,113 $1,956,999,329 +$8,535,324 $47.70 189
2017 Q1 40,931,045 $1,867,446,801 +$210,167,571 $45.60 187
2016 Q4 39,927,479 $1,289,568,433 +$17,822,300 $32.30 177
2016 Q3 39,409,548 $1,348,420,206 -$48,771,750 $34.22 175
2016 Q2 40,740,565 $1,374,319,414 -$218,674,282 $33.73 180
2016 Q1 42,925,392 $2,273,932,256 -$33,989,505 $52.98 173
2015 Q4 42,051,373 $3,229,264,952 +$16,604,398 $76.79 209
2015 Q3 41,666,151 $1,712,628,594 -$38,692,093 $41.10 174
2015 Q2 42,384,390 $2,996,728,743 +$146,718,378 $70.72 185
2015 Q1 40,290,746 $3,580,894,141 +$97,518,391 $88.85 204
2014 Q4 37,884,751 $3,359,600,536 -$15,173,612 $88.66 196
2014 Q3 38,560,861 $3,736,934,189 +$109,945,683 $96.92 204
2014 Q2 37,574,324 $3,451,152,168 +$245,159,182 $91.86 188
2014 Q1 35,062,481 $2,453,913,086 +$23,224,728 $69.99 158